期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Percutaneous local therapies for hepatocellular carcinoma impair gastric function 被引量:2
1
作者 Fumihiko Kinekawa Kazuya Matsuda +7 位作者 Tsutomu Masaki Kazutaka Kurokohchi Hirohito Yoneyama Hideyuki Inoue hirohide kurata Yoshihito Uchida Seishiro Watanabe Shigeki Kuriyama 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第1期157-158,共2页
Percutaneous local therapies, such as percutaneous ethanol injection (PEI), microwave coagulation and radiofrequency ablation (RFA), are frequently used worldwide for the treatment of hepatocellular carcinoma (HC... Percutaneous local therapies, such as percutaneous ethanol injection (PEI), microwave coagulation and radiofrequency ablation (RFA), are frequently used worldwide for the treatment of hepatocellular carcinoma (HCC) because of their high effectiveness. Although these treatment modalities can induce effectively coagulated tumor necrosis in the liver, they may cause adverse effects on extrahepatic abdominal organs. There are, however, no published reports on the influence of percutaneous local therapies on the gastric myenteric activity. Therefore, it is unclear whether or not gastric function is affected by percutaneous local therapies. In this study, to make clear the effect of PEI and RFA on the gastric function, we continuously recorded the gastric myoelectric activity by electrogastrography (EGG) and estimated the effect of percutaneous local therapies for HCC on gastric function. 展开更多
关键词 ELECTROGASTROGRAPHY Gastric myentericactivity Hepatocellular carcinoma Percutaneous ethanolinjection Radiofrequency ablation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部